UBS Group AG - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 32 filers reported holding OCUPHIRE PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q2 2023$37,979
+1695.7%
8,751
+1451.6%
0.00%
Q1 2023$2,115
-29.5%
564
-66.8%
0.00%
Q3 2022$3,000
-40.0%
1,700
-31.1%
0.00%
Q2 2022$5,000
-73.7%
2,466
-57.1%
0.00%
Q1 2022$19,000
-29.6%
5,748
-19.6%
0.00%
Q4 2021$27,000
-34.1%
7,145
-8.8%
0.00%
Q3 2021$41,000
+36.7%
7,838
+41.4%
0.00%
Q2 2021$30,000
+172.7%
5,542
+206.2%
0.00%
Q1 2021$11,0001,8100.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders